swaminathan iyer, md, on how romidepsin can be incorporated into the treatment of t cell lymphoma
Published 7 years ago • 192 plays • Length 1:59
Download video MP4
Download video MP3
Similar videos
-
1:40
swaminathan iyer, md, discusses how to incorporate ofatumumab into the treatment of cll
-
1:35
swaminathan p. iyer, md, regarding improvements in the treatment of ctcl
-
4:47
how could azacitidine with romidepsin be integrated into the treatment pathway of t-cell lymphomas?
-
3:55
the standard of care in t-cell lymphoma: challenges and future outlooks
-
36:52
part 7 - new era of car-t in lymphoma - dr. swaminathan p. iyer, usa
-
3:07
categorizing subsets of t-cell lymphoma to improve trial design and treatment approaches
-
2:37
swaminathan iyer, md, discusses intriguing data on cll presented at ash 2016
-
3:08
the role of the microenvironment in t-cell lymphoma and the promise of pembrolizumab in this disease
-
1:52
unmet needs in the treatment of t-cell malignancies
-
2:32
unmet needs in t-cell lymphoma and the importance of better understanding disease biology
-
1:31
eha 2023 t-cell lymphoma highlights
-
7:52
highlights in t-cell lymphoma: unmet needs, clinical trial updates, and future outlooks
-
2:23
romidepsin and azacitidine in patients with r/r t-cell lymphoma
-
2:23
swaminathan padmanabhan iyer, md, on if echelon-2 study is game changing for patients with ptcl
-
10:48
what's on the horizon for t-cell lymphoma therapy?
-
3:52
what is in the future for t-cell lymphoma?
-
11:44
how immunotherapies are re-shaping the treatment of lymphoma
-
1:58
updates from the cobalt-lym study: ctx130 in patients with r/r t-cell malignancies
-
1:11
hdacis in treating r/r ptcl
Clip.africa.com - Privacy-policy